Business

BusinessMay 21, 2024

Is Compass Pathways Poised for Success?

BlogJanuary 26, 2024

5 Risks While Operating in the Psychedelics Industry in 2024

BlogAugust 18, 2023

How Crowdfunding is Fueling Growth in the Psychedelic Industry

BlogAugust 16, 2023

Cybin Finacial Analysis: Future Prospects are Uncertain

BlogAugust 7, 2023

Braxia Scientific Financial Report Analysis

BlogAugust 2, 2023

Cybin Brings in Capital with Public Offering

BlogAugust 1, 2023

Psychedelic Access is Coming to California

BlogJuly 28, 2023

Numinus Earnings Report Analysis— Q3 2023: Bullish Vs Bearish?

BusinessJuly 19, 2023

UC Berkeley Survey: Understanding Voter Attitudes Towards Psychedelic Legalization

BlogMay 22, 2023

Unleashing the Full Potential of Psychedelic Therapy

BlogMay 11, 2023

Is the American Medical Association Ready for Psychedelics?

BlogMay 2, 2023

Oregon’s Psilocybin Marketplace Could Be Facing a Serious Bottleneck

BlogApril 18, 2023

Ways Your Psychedelic Business Can Avoid Insurance Landmines

BlogApril 13, 2023

What Can The Industry Learn From Field Trip Health’s Downfall?

BusinessJune 10, 2020

Psychedelic Invest releases free Investor Guidebook

BusinessMay 21, 2020

German Cannabis Distributor Signs LOI to Acquire Dutch Psychedelic Company

BusinessMay 18, 2020

Psychedelic Company, Numinus, to go Public

BusinessMay 15, 2020

Canadian Cannabis Company Set To Acquire German Psychedelic Facility

BusinessMay 14, 2020

This Danish Psychedelic Company Turns Yeast Into Psilocybin

BusinessApril 17, 2020

Former Red Bull exec joins psychedelic company

BusinessApril 17, 2020

MindMed gets upgraded trading status

BusinessApril 1, 2020

Why Kevin O’Leary is Investing in Psychedelics

BusinessMarch 2, 2020

Will California Decriminalize Psychedelic Mushrooms?

BusinessFebruary 24, 2020

Psychedelic Company Buys Rights For Mushroom Extraction